@article{824469,
      recid = {824469},
      author = {Usmani, Saad Z. and Nooka, Ajay K.},
      title = {Personalized therapy for multiple myeloma /},
      publisher = {Springer,},
      address = {Cham :},
      pages = {1 online resource (183 pages)},
      year = {2018},
      abstract = {This book provides the clinician with concise, practical  guidance on risk stratification and therapeutic decision  making in patients with multiple myeloma. In addition, the  available clinical trial and research data are summarized  into meaningful reviews and evidence-based recommendations  for treatment are presented. The coverage encompasses all  phases and forms of disease, including high-risk myeloma.  Over recent decades, greater understanding of the biology  of myeloma has fostered the development of new, more  effective drugs, leading to remarkable improvements in  survival. To continue this momentum, several recent  prospective trials have aimed to identify further potential  therapeutic targets or to evaluate various combinations of  anti-myeloma agents. The increasing abundance of management  options makes treatment decision making in different phases  of disease. This book will offer the clinician valuable  assistance in the choice and sequencing of therapies,  highlighting the need for a personalized approach that  reflects the growing recognition that myeloma is not one  uniform disease.},
      url = {http://library.usi.edu/record/824469},
      doi = {https://doi.org/10.1007/978-3-319-61872-2},
}